Mercator Medical (FRA:MM2) LT-Debt-to-Total-Asset: 0.02 (As of Mar. 2026)

What is Mercator Medical LT-Debt-to-Total-Asset?

Mercator Medical FRA:MM2 -1.96% 60 LT-Debt-to-Total-Asset is 0.02 as of Mar. 2026. GuruFocus rates FRA:MM2 with a GF Score™ of 60/100 and a GF Value™ of €11.55 (Fairly Valued). The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Mercator Medical's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.02.

Mercator Medical's long-term debt to total assets ratio increased from Mar. 2025 (0.00) to Mar. 2026 (0.02). It may suggest that Mercator Medical is progressively becoming more dependent on debt to grow their business.

Mercator Medical (FRA:MM2) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Mercator Medical LT-Debt-to-Total-Asset Related Terms

Mercator Medical LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Mercator Medical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical LT-Debt-to-Total-Asset Chart

Mercator Medical Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.00

0.01

0.00

0.02

Mercator Medical Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.02	0.02	0.02	0.02

60GF Score

Mercator Medical SA FRA:MM2

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Mercator Medical LT-Debt-to-Total-Asset Calculation

Mercator Medical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	4.213	/	239.777
	=	0.02

Mercator Medical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	3.854	/	242.755
	=	0.02

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.02 mean?

Mercator Medical (FRA:MM2) has a LT-Debt-to-Total-Asset of 0.02 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Mercator Medical and its competitors.

Is Mercator Medical's LT-Debt-to-Total-Asset too high?

Mercator Medical's current LT-Debt-to-Total-Asset is 0.02. Overall, Mercator Medical has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Mercator Medical's LT-Debt-to-Total-Asset compare to ISRG and BDX?

Mercator Medical's LT-Debt-to-Total-Asset of 0.02 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Mercator Medical and its competitors. Mercator Medical's current LT-Debt-to-Total-Asset is 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Mercator Medical stock overvalued right now?

Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €11.55, compared to a current price of €10.98 — trading 4.9% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.02. Mercator Medical's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current LT-Debt-to-Total-Asset is 0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be undervalued. The current stock price of €10.98 is trading 4.9% below its estimated GF Value™ of €11.55. GuruFocus considers Mercator Medical to be Fairly Valued.

Key valuation signals for FRA:MM2:

LT-Debt-to-Total-Asset: 0.02
GF Value™: €11.55 vs. price of €10.98 (4.9% below fair value)
GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies WAR:AWM ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543 XPAR:DIM COO SOLV OCSE:COLO B NZSE:FPH ALGN BAX NSE:LENSKART RGEN

Other Exchanges MRC:Poland

Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327

Website http://www.mercatormedical.eu

Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.

60GF Score

Get the complete analysis for FRA:MM2

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.98

Price

€11.55

GF Value

View FRA:MM2 Analysis

See LT-Debt-to-Total-Asset data for all stocks →